| Product Code: ETC9399648 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Cell And Gene Therapy Manufacturing Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Cell And Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 South Korea Cell And Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F |
3.7 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 South Korea Cell And Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in cell and gene therapy technologies |
4.2.2 Favorable government regulations and policies supporting cell and gene therapy manufacturing industry |
4.2.3 Growing demand for personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 High costs associated with cell and gene therapy manufacturing processes |
4.3.2 Limited skilled workforce and expertise in advanced bioprocessing techniques |
4.3.3 Challenges in scaling up production to meet market demand |
5 South Korea Cell And Gene Therapy Manufacturing Market Trends |
6 South Korea Cell And Gene Therapy Manufacturing Market, By Types |
6.1 South Korea Cell And Gene Therapy Manufacturing Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F |
6.1.4 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F |
6.2 South Korea Cell And Gene Therapy Manufacturing Market, By Scale |
6.2.1 Overview and Analysis |
6.2.2 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F |
6.2.3 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F |
6.3 South Korea Cell And Gene Therapy Manufacturing Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F |
6.3.3 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F |
6.4 South Korea Cell And Gene Therapy Manufacturing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F |
6.4.3 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F |
6.4.4 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F |
6.4.5 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F |
6.4.6 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F |
6.4.7 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F |
6.4.8 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 South Korea Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Cell And Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 South Korea Cell And Gene Therapy Manufacturing Market Export to Major Countries |
7.2 South Korea Cell And Gene Therapy Manufacturing Market Imports from Major Countries |
8 South Korea Cell And Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Number of new partnerships and collaborations within the cell and gene therapy manufacturing industry |
8.2 Percentage increase in government funding allocated to support cell and gene therapy manufacturing |
8.3 Rate of adoption of advanced manufacturing technologies in the cell and gene therapy sector |
8.4 Number of clinical trials and approvals for cell and gene therapy products in South Korea |
8.5 Employee training and development initiatives focusing on bioprocessing techniques. |
9 South Korea Cell And Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 South Korea Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 South Korea Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F |
9.3 South Korea Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 South Korea Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 South Korea Cell And Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 South Korea Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 South Korea Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here